New Real-World Data Further Support the Use of Veklury® (Remdesivir) for People Hospitalized With COVID-19
Gilead Sciences, Inc. (Nasdaq: GILD) today announced new data from three real-world retrospective studies being presented at the…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
06 Mar 24
Gilead Sciences, Inc. (Nasdaq: GILD) today announced new data from three real-world retrospective studies being presented at the…
06 Mar 24
March 4th 2024 marks the 7th International HPV Awareness Day, a global campaign proposed by the International Papillomavirus…
04 Mar 24
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products,…
29 Feb 24
The FDA has set a PDUFA target action date of 28 August 2024 for the investigational, Aldose Reductase…
29 Feb 24
Greenway Patient Connect aims to support three daily elements of a patient’s experience - access, communication, and readiness.
29 Feb 24
Biofourmis' care-at-home solutions include wearable devices, digital platforms, and in-home services orchestration technology.
29 Feb 24
FDA-approved generic provides cost-effective option for treating cancer
28 Feb 24
Under the agreement, Italy-based Zambon will seek regulatory approval and market IPX203 in the European Union, UK, and…
28 Feb 24
AbbVie seeks approval for epcoritamab to treat adults with relapsed or refractory (R/R) FL after two or more…
28 Feb 24
The FDA approved Exblifep (cefepime/enmetazobactam) based on a comprehensive set of clinical data showing the drug's efficacy against…